iPSC-Derived Striatal Neurons

iPSC-Derived Striatal Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">iPSC-Derived Striatal Neurons</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>iPSC > Neural Progenitor > Striatal Neuron</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>MAP2, DARPP-32, CTIP2, SP8, ISL1</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Striatum - Caudate, Putamen</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>Huntington's Disease, Parkinson's Disease, Dystonia</td>
</tr>
</table>

iPSC-Derived Striatal Neurons

Introduction

Ipsc Derived Striatal Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

...

iPSC-Derived Striatal Neurons

<table class="infobox infobox-celltype">
<tr>
<th class="infobox-header" colspan="2">iPSC-Derived Striatal Neurons</th>
</tr>
<tr>
<td class="label">Lineage</td>
<td>iPSC > Neural Progenitor > Striatal Neuron</td>
</tr>
<tr>
<td class="label">Markers</td>
<td>MAP2, DARPP-32, CTIP2, SP8, ISL1</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Striatum - Caudate, Putamen</td>
</tr>
<tr>
<td class="label">Disease Relevance</td>
<td>Huntington's Disease, Parkinson's Disease, Dystonia</td>
</tr>
</table>

iPSC-Derived Striatal Neurons

Introduction

Ipsc Derived Striatal Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

iPSC-derived striatal neurons are medium spiny neurons (MSNs) and interneurons generated from human induced pluripotent stem cells that model the striatum, the primary input nucleus of the basal ganglia. These neurons express the characteristic marker DARPP-32 (PPP1R1B) and exhibit GABAergic signaling with the electrophysiological properties of authentic medium spiny neurons["@carri2013"][@delli2018].

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

| Taxonomy | ID | Name / Label |
|----------|----|---------------|

External Database Links

• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Differentiation Protocol

Patterning to Striatal Fate

Striatal differentiation employs patterning factors that specify lateral and medial ganglionic eminence (LGE/MGE) identities:

• SHH (Sonic Hedgehog): Specifies ventral telencephalic fate
• BDNF: Supports neuronal survival and maturation
• RA (Retinoic Acid): Promotes striatal specification
• DAA (Dickkopf-1): Inhibits Wnt signaling for ventral patterning

Maturation Timeline

• Days 0-10: Neural rosette formation
• Days 10-25: LGE/MGE patterning
• Days 25-45: Striatal neuron specification
• Days 45-90: Neuronal maturation and process extension

Medium Spiny Neuron Subtypes

D1-MSNs (Direct Pathway)

Express DRD1 (dopamine receptor D1) and project to the substantia nigra pars reticulata (SNr). Activation promotes movement initiation.

D2-MSNs (Indirect Pathway)

Express DRD2 (dopamine receptor D2) and project to the globus pallidus externus (GPe). Activation inhibits movement.

Disease Modeling

Huntington's Disease

iPSC-derived MSNs from HD patients exhibit:

• Mutant huntingtin protein aggregation
• Reduced DARPP-32 expression
• Electrophysiological dysfunction
• Increased vulnerability to excitotoxicity
• Mitochondrial deficits[@ipsc2012][@nekrasov2016]

Parkinson's Disease

Striatal neurons model dopaminergic denervation and subsequent:

• Dysregulated DARPP-32 signaling
• Altered BDNF expression
• Synaptic dysfunction

Dystonia

Patient-derived neurons reveal cellular mechanisms underlying involuntary movements.

Electrophysiology

• Resting membrane potential: -70 to -80 mV
• Hyperpolarization-activated currents (Ih)
• Depolarized resting potential due to high Na+ leak conductance
• Action potentials with variable firing patterns
• GABAergic synaptic activity

Therapeutic Applications

Drug Screening

Platform for testing compounds that:

• Reduce mutant huntingtin aggregation
• Enhance mitochondrial function
• Modulate dopaminergic signaling
• Promote neuronal survival

Cell Replacement Therapy

Clinical trials are investigating striatal neuron transplantation for Huntington's disease[@bachoudlevi2019].

See Also

• [Brain Organoid Neurons
• [iPSC-Derived Hippocampal Neurons](/cell-types/ipsc-derived-hippocampal-neurons)
• [Nigrostriatal Pathway Dopaminergic Neurons](/cell-types/brain-organoid-neurons](/cell-types/nigrostriatal-pathway-dopaminergic)
• [Huntington's Disease](/diseases/huntingtons)

Background

The study of Ipsc Derived Striatal Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [Huntington's Disease Society of America](https://hdsa.org/) - Patient resources
• [Michael J. Fox Foundation](https://www.michaeljfox.org/) - Parkinson's research
• [NIH NeuroBioBank](https://neurobiobank.nih.gov/) - Human tissue samples

Pathway Diagram

The following diagram shows the key molecular relationships involving iPSC-Derived Striatal Neurons discovered through SciDEX knowledge graph analysis: